Price (delayed)
$0.55
Market cap
$31.86M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.28
Enterprise value
$31.09M
Homology Medicines, Inc. is a clinical-stage genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying
There are no recent dividends present for FIXX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.